February 9, 2023 Blood was drawn from 16 breast cancer patients and enriched for Circulating Tumor Cells (CTCs) using LiquidScan. Isolated cells were analyzed for HER2 positivity [Read More...]
About BioFluidicaBioFluidica's LiquidScan is the future of liquid biopsy. LiquidScan combines cutting-edge microfluidics and automation hardware for precision medicine for multiple cancers and prenatal diagnostics testing. LiquidScan isolates and enriches rare cells and exosomes from liquid biopsy samples.
February 9, 2023 BioFluidica attended the Precision Medicine World Conference (PMWC) 2023 on January 25-27th. Every year PMWC gathers top researchers and medical professionals from all over [Read More...]
November 1 - 5 BioFluidica attended the Association for Molecular Pathology (AMP) 2022 Annual Meeting and Expo this week, showcasing their LiquidScan technology. AMP is the leading [Read More...]
By Jamie Reno, June 15, 2022 BioFluidica presented its LiquidScan, a microfluidic chip that searches a blood sample for rare biomarkers such as CTCs (circulating tumor cells), cell-free [Read More...]
June 3 - 7, 2022 BioFluidica attended the ASCO Annual Meeting, exhibiting at Booth 21160 and presenting a poster abstract about the results of a patient sample [Read More...]
San Diego Union Tribune | By Bradley J. Fikes, August 31, 2018 Blood is hard to beat for detecting disease. This liquid tissue circulates throughout the body, picking up [Read More...]